fbpx

Medicines Advice Initiative Australia (MAIA): supporting quality use of medicines

image of a team of medical staff with hands in the middle
MAIA and PSA logos

Medicines Advice Initiative Australia (MAIA) is a consortium dedicated to improving the use of medicines and related health services in Australia.

  

This consortium is led by the Quality Use of Medicines and Pharmacy Research Centre at the University of South Australia in collaboration with: 

 

  • the Australian Medicines Handbook (AMH) 
  • the Drug and Therapeutics Information Service (DATIS)  
  • the Discipline of General Practice Adelaide University  
  • the National Aboriginal Community Controlled Health Organisation (NACCHO) 
  • the Pharmaceutical Society of Australia (PSA)  
  • the Council of Australian Therapeutic Advisory Groups (CATAG).  

 

The consortium will develop educational interventions that target a specific health care problem and make them available to all General Practitioners in Australia. Specific resources will be created for health professionals working in Aboriginal Community Controlled Health Organisations (ACCHOs) through NACCHO, credentialed pharmacists through PSA, and hospitals and health service organisations through CATAG.

 

Supported by the educational intervention, MAIA aims to create positive interactions with the broader health system, by a Primary Health Network (PHN) engagement strategy, the development of data driven innovations and research comparing the effectiveness of different educational messaging. These initiatives will enhance the program, improve the usefulness of the interventions and enable digital tools to support GPs, ACCHOs, pharmacists and health organisations to effect change in their patient population. 

 

More information

Link to MAIA website
Link to Credentialed pharmacist PSA

Therapeutic Topics 

Explore the tailored education opportunities and resources developed for credentialed pharmacists on each of these topics. 

Link to Reducing the Risk of Cumulative Medicines
Link to Persistent Pain
Link tile to Medicines and the kidney
Link to Managing CVD and CKD risk in type 2 diabetes
Heart failure tile only

Medicines Advice Initiative Australia (MAIA) is provided to you by University of South Australia Quality Use of Medicines and Pharmacy Research Centre | In association with: Australian Medicines Handbook (AMH) | Drug and Therapeutics Information Service (DATIS) | Discipline of General Practice, University of Adelaide | National Aboriginal Community Controlled Health Organisation (NACCHO) | Pharmaceutical Society of Australia (PSA) | Council of Australian Therapeutic Advisory Groups (CATAG).  

MAIA is funded by the Australian Government through the Quality Use of Diagnostics, Therapeutics and Pathology Program. 

MAIA materials are adapted from the Veterans’ MATES program materials.  “This material is used under licence from the Australian Government, © Commonwealth of Australia, Department of Veterans’ Affairs 2023”. The views expressed in the MAIA materials do not necessarily represent the views of the Minister for Veterans’ Affairs or the Department of Veterans’ Affairs.  The Commonwealth does not give any warranty nor accept any liability in relation to the content or use of this material.”  

Department of veteran affairs logo